Finished product reference
Dimethylglycine
Capsule · Oral · 125 mg
- List code
- 51006
- Pharmacologic class
- Nutritional supplement (amino acid derivative)
What it is and how it works
N,N-dimethylglycine is a derivative of glycine and an intermediate in choline and betaine metabolism, acting as a methyl-group donor in one-carbon metabolism. Claimed benefits on immune function, athletic performance and neurodevelopmental conditions are not supported by robust clinical evidence.
Indications
Marketed as a dietary supplement; it has no well-established approved therapeutic indication.
Contraindications
Hypersensitivity to the substance.
Warnings and precautions
Clinical efficacy has not been established in controlled trials, and it should not replace established treatments. Safety data in children, in pregnancy and with long-term use are limited.
Pregnancy
Safety in pregnancy has not been established; avoid unless advised by a doctor.
Storage and supply
Store below 25 °C in a dry place.
Source: reference summary prepared from the EU SmPC/EPAR, BNF and WHO Model Formulary. The approved product information in Iran governs.
Reference information for professional sourcing and registration enquiries, not medical advice or a promotion. Drug information is condensed from US FDA prescribing information (public domain, via openFDA and DailyMed) and does not replace the product’s approved labelling in Iran. Availability, origin and documentation are confirmed per enquiry.
Tell us the quantity, the market and the timing.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.